Cargando…
Personalised medicine in interstitial lung diseases: Number 6 in the Series “Personalised medicine in respiratory diseases” Edited by Renaud Louis and Nicolas Roche
Interstitial lung diseases in general, and idiopathic pulmonary fibrosis in particular, are complex disorders with multiple pathogenetic pathways, various disease behaviour profiles and different responses to treatment, all facets that make personalised medicine a highly attractive concept. Personal...
Autores principales: | Kokosi, Maria A., Margaritopoulos, George A., Wells, Athol U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488852/ https://www.ncbi.nlm.nih.gov/pubmed/29653950 http://dx.doi.org/10.1183/16000617.0117-2017 |
Ejemplares similares
-
Personalised medicine in asthma: time for action: Number 1 in the Series “Personalised medicine in respiratory diseases” Edited by Renaud Louis and Nicolas Roche
por: Chung, Kian Fan
Publicado: (2017) -
Personalised medicine for nonsmall cell lung cancer
por: Mascaux, Céline, et al.
Publicado: (2017) -
Multidisciplinary evaluation of interstitial lung diseases: current insights: Number 1 in the Series “Radiology” Edited by Nicola Sverzellati and Sujal Desai
por: Walsh, Simon L.F.
Publicado: (2017) -
Personalised pulmonary rehabilitation in COPD
por: Wouters, Emiel F.M., et al.
Publicado: (2018) -
Personalised medicine in sleep respiratory disorders: focus on
obstructive sleep apnoea diagnosis and treatment
por: Bonsignore, Maria R., et al.
Publicado: (2017)